Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doctor’s Choice was a Florida-based healthcare services company focused on home health and hospice care rather than a drug-development biotech or pharma model. The company operated as an independent provider of home health services in Florida and offered care for patients in the home, including skilled nursing and related support services. In April 2021, Aveanna acquired Doctor’s Choice for approximately $115 million in cash consideration, and the business was subsequently integrated into Aveanna Home Health. As a result, Doctor’s Choice is best understood as a former post-acute care services company in the healthcare delivery sector, not a therapeutic product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doctor’s Choice Holdings.